64 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
6 Feb 07
Ligand Announces Corporate Restructuring
12:00am
to its new business model, by reducing its workforce by about 267 positions or approximately 76 percent.
Key elements of the restructuring are as follows … of this release. These statements include those related to reductions in workforce, facilities consolidation, operating savings, transformation
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
12 Dec 07
Cost Associated with Exit or Disposal Activities
12:00am
Activities.
On December 11, 2007, Ligand Pharmaceuticals Incorporated (the “Company”) commenced a plan to reduce the Company’s workforce … to statements with respect to the expected timing for completion of the workforce reduction plan and the estimated charges to be incurred as a result
424B3
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
6 Feb 07
Prospectus supplement
12:00am
is reducing its workforce by about 267 positions or approximately 76 percent, based on total employment of 352 as of December 31, 2006. Included … Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that it is restructuring its business, pursuant to its new business model, by reducing its workforce
8-K
EX-99
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
15 Mar 07
Results of Operations and Financial Condition
12:00am
.
In accordance with the corporate restructuring announced in January
2007, the Company's full-time workforce will be reduced by approximately 76 … product lines. Further, we
may not be able to complete our reductions in workforce on any particular or
expected timeframe, we may not realize significant
8-K
EX-99
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
23 Mar 07
Other Events
12:00am
to complete our reductions in workforce on any particular or
expected timeframe, we may not realize significant operating savings due to our
424B3
3plqmux
15 Mar 07
Prospectus supplement
12:00am
8-K
huube7ltf38
6 Feb 07
Ligand Announces Corporate Restructuring
12:00am
8-K
EX-99.1
vc45j5h1 v2md9e4i0
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
424B3
hwvecsph9qp45qj10
23 Mar 07
Prospectus supplement
12:00am
8-K
EX-99.1
gduc1qm
10 May 07
Ligand Pharmaceuticals Announces First Quarter Results
12:00am
8-K
EX-99
23u21b18
8 Nov 07
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
vstw2 uyglfutxvl0g
20 Feb 08
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
12:00am
8-K
EX-99
zf0mrcm
8 Aug 07
Results of Operations and Financial Condition
12:00am
8-K/A
EX-99.2
o2g3x2142gt49bim1
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
p5bj60
8 Nov 18
Ligand Reports Third Quarter 2018 Financial Results
8:13am